WithdrawnNCT01309685
Effect of Varenicline on Tobacco Addiction and on Abstinence-induced Cognitive Impairment
Medication studyAges 18–50
Understand this study
Who could participate?
Listed age limits: 18 years to 50 years.
What will I do during this study?
The protocol includes questionnaires about smoking and mood, memory and attention tests, and blood and urine samples.
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateFebruary 13, 2011
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- National Institute on Drug Abuse (NIDA)
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- Not clearly listed
- Age range
- From 18 Years to 50 Years
- Official registry ID
- NCT01309685
- Official title
Show the full official title
Effect of Varenicline on a Laboratory Model of Tobacco Addiction and on Withdrawal-Induced Cognitive Impairment
Recruitment & locations
WithdrawnThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Locations not listed
Interested in joining this study?
Questions about this study
What will I need to do?
You will provide blood samples.
Who is behind this study?
The study sponsor is National Institute on Drug Abuse (NIDA), a research institute.
Does this study involve medication?
Yes. The study involves medication, including Varenicline.
Who can participate?
Listed age limits: 18 years to 50 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
